Overview
Yujia Ye practices practicing medicine in Kunming, China.
Their clinical expertise encompasses Autosomal Recessive Cutis Laxa Type 1, Atrial Myxoma, Cutis Laxa, and Acute Coronary Syndrome.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yujia Ye
Is Yujia Ye a top-rated expert for Autosomal Recessive Cutis Laxa Type 1?
MediFind is an objective health platform that identifies experts based on real-world data. Yujia Ye is classified as an Experienced expert for Autosomal Recessive Cutis Laxa Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yujia Ye participate in research or clinical trials?
Yes. Yujia Ye has published 20 articles and abstracts on conditions like Autosomal Recessive Cutis Laxa Type 1. You can view a list of Yujia Ye's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Coronary SyndromeYe isExperienced. Learn about Acute Coronary Syndrome.
- Atrial MyxomaYe isExperienced. Learn about Atrial Myxoma.
- Autosomal Recessive Cutis Laxa Type 1
- Cutis LaxaYe isExperienced. Learn about Cutis Laxa.